Michael Eberlein, MD, PhD, Robert M

Slides:



Advertisements
Similar presentations
Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis  Eric S. Weiss, MD, MPH, Jeremiah G. Allen,
Advertisements

Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S
What Predicts Long-Term Survival After Heart Transplantation
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Lung Transplant Mortality Is Improving in Recipients With a Lung Allocation Score in the Upper Quartile  Todd C. Crawford, MD, Joshua C. Grimm, MD, J.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Outcomes of Reintervention on the Autograft After Ross Procedure
Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer  Lars P. Riber, MD, PhD, Thomas D. Christensen,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation  Arman Kilic, MD,
Double-Lung Transplantation Can Be Safely Performed Using Donors With Heavy Smoking History  Sharven Taghavi, MD, MPH, Senthil Jayarajan, MD, Eugene Komaroff,
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Surgical Ventricular Restoration: Is There Any Difference in Outcome Between Anterior and Posterior Remodeling?  Andrea Garatti, MD, Serenella Castelvecchio,
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations  Giovanni Filardo, PhD, MPH, Paul.
Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,
B. Zane Atkins, MD, Rebecca P. Petersen, MD, MS, Mani A
Castigliano M. Bhamidipati, DO, MS, George J
Less Is More in Post Pediatric Heart Transplant Care
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Operative Results and Outcomes in Children With Shone's Anomaly
Mark D. Iannettoni, MD, William R. Lynch, MD, Kalpaj R
Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M
Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D
Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases  Haifeng Wang, MM, Hongsheng Lin, MM, Gening.
Long-Term Outcomes of the Mosaic Bioprosthesis
Lung Cancer Surgery in Patients With Liver Cirrhosis
Radial Artery Grafts in Women: Utilization and Results
Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery  James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,
Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R
Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis  Shahid I. Sheikh, MD, Don Hayes,
Use of Amiodarone After Major Lung Resection
Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E
Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence  Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,
Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices?  Jeremiah G. Allen, MD, Arman.
Lung Function and ECMO After Lung Transplantation
Outcomes of Delayed Chest Closure After Bilateral Lung Transplantation
Acute Kidney Injury Increases Mortality After Lung Transplantation
Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D
Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A
Understanding Mortality as a Quality Indicator After Esophagectomy
William M. Whited, MD, Paul Henley, BS, Erin M
Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection  Emilie Perrot, MD, Benoit Guibert, MD, Pierre Mulsant,
Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients  Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.
A. Thomas Pezzella, MD, Sari D
Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent?  Raheel Rizwan, MD, Farhan Zafar, MD, Clifford Chin, MD, James Tweddell, MD,
Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S
Single Versus Double Lung Retransplantation Does Not Affect Survival Based on Previous Transplant Type  Erin M. Schumer, MD, MPH, Jonathan D. Rice, MD,
Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer  Pamela Samson, MD, MPHS, Varun.
Bleeding Complications and Blood Product Utilization With Left Ventricular Assist Device Implantation  Justin M. Schaffer, MS, George J. Arnaoutakis,
Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?  Anna Lee, MD, MPH, Andrew T.
Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F
Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study  Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population  Christian McNeely, MD, Stephen.
“Prophylactic” Tricuspid Repair for Functional Tricuspid Regurgitation
Preoperative Performance Status Impacts Perioperative Morbidity and Mortality After Lung Transplantation  Joshua C. Grimm, MD, Vicente Valero, MD, Arman.
The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure  Nathan Wm. Skelley, BS, Jeremiah.
Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients  Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,
Mark Ruzmetov, MD, PhD, Dale M. Geiss, MD, Jitendra J
Christian A. Bermudez, MD, Rodolfo V
Lung Retransplantation for Chronic Rejection: A Single-Center Experience  Sreeja Biswas Roy, MBBS, Roshan Panchanathan, BS, Rajat Walia, MD, Katherine.
Reoperation for Coronary Artery Bypass Grafting Surgery: Outcomes and Considerations for Expanding Interventional Procedures  Simon Maltais, MD, PhD,
Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement  Heinrich Koertke, MD,
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy  Tomas Gudbjartsson,
Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms  Robert E. Merritt, MD, Douglas J. Mathisen,
Presentation transcript:

Lung Size Mismatch and Survival After Single and Bilateral Lung Transplantation  Michael Eberlein, MD, PhD, Robert M. Reed, MD, Servet Bolukbas, MD, Kalpaj R. Parekh, MD, George J. Arnaoutakis, MD, Jonathan B. Orens, MD, Roy G. Brower, MD, Ashish S. Shah, MD, Lawrence Hunsicker, MD, Christian A. Merlo, MD, MPH  The Annals of Thoracic Surgery  Volume 96, Issue 2, Pages 457-463 (August 2013) DOI: 10.1016/j.athoracsur.2013.04.064 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 One-year Kaplan-Meier survival estimates according to pTLC-ratio quartiles (1 = undersized; 2 = matched; 3 = oversized; 4 = very-oversized). (A) Bilateral lung transplant patients. The mean pTLC-ratio from quartile 1 to 4 was 0.82 ± 0.08 (undersized), 0.98 ± 0.03 (size-matched), 1.08 ± 0.05 (oversized), and 1.30 ± 0.14 (very oversized). (B) Single lung transplant patients. The mean pTLC-ratio from quartile 1 to 4 was 0.83 ± 0.08 (undersized), 0.99 ± 0.03 (size-matched), 1.08 ± 0.03 (oversized) and 1.31 ± 0.14 (very oversized). Comparisons between pTLC-ratio quartiles by log-rank test. (pTLC = predicted total lung capacity.) The Annals of Thoracic Surgery 2013 96, 457-463DOI: (10.1016/j.athoracsur.2013.04.064) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions